Skip to main content
Psychopharmacology Bulletin logoLink to Psychopharmacology Bulletin
. 2023 Feb 28;53(1):39–45.

Captagone & Morbid Jealousy

Amr Said Shalaby 1, Osama Mohamed Badr Nassar 2, Abdullah Osama Bahanan 3, Mishal Hasan Alshehri 4, Nasr Farid Nasr Abou Elzahab 5
PMCID: PMC9981336  PMID: 36873918

Abstract

This study aimed to explore the relationship between Captagon usage and the development of delusions of infidelity. The study sample; 101 male patients, was recruited from patients admitted to Eradah Complex for Mental Health and addiction, Jeddah, Saudi Arabia, with the diagnosis of amphetamine (Captagon) induced psychosis during the period from September 2021 to March 2022. All patients underwent an extensive psychiatric interview; including interview with patients’ families; a demographic sheet, a drug use questionnaire, the structured clinical interview for DSM-IV (SCID 1), routine medical investigation, and urine screening for drugs. Patients’ ages ranged from 19 to 46 years old with Mean ± SD 30.87 ± 6.58. 57.4 % were single, 77.2% have finished their high school, and 22.8% had no work. Captagon using age ranged from 14–40 years old, and regular daily dose ranged from 1–15 tablet, while maximum daily dose ranged from 2–25 tablets. Twenty-six patients (25.7%) of the study group have developed infidelity delusions. A higher divorce rate was present among patients who developed infidelity delusions (53.8%) in comparison to patients who developed other types of delusions (6.7%). Infidelity delusions are common among patients diagnosed with Captagon induce psychosis, and they harmfully influence their social lives.

Keywords: Captagon, psychosis, morbid jealousy, infidelity delusions

Introduction

Although the use of Captagon is currently banned around the world, it is still illegally, manufactured and used in different Eastern European and Middle Eastern countries. It is one of the most used illegal substances in Saudi Arabia.1

Fenethylline is the psychoactive substance in Captagon which is mainly responsible for its central nervous system stimulant effect.2

Amphetamine induced psychosis is prevalent among individuals who use these drugs. Psychosis appears while an individual is under the influence of the drug, and disappears when the drug is no longer in the body.3

The dominant theme in morbid jealousy is a preoccupation with a partner’s sexual unfaithfulness. In contrast to healthy people, morbidly jealous individuals interpret conclusive evidence of infidelity from irrelevant occurrences. Delusions, obsessions, and overvalued ideas are the most commonly psychopathological forms in morbid jealousy.4

Although its prevalence is not precisely known, morbid jealousy is not uncommonly encountered in daily clinical practice. It can be presented as the patient sole complaint or as a component of the psychopathology of other psychiatric disorders. According to Singh, Bhandari, and Singh,5 its frequency in psychiatric outdoor was found to be 7.59% with delusional jealousy being the commonest followed by overvalued idea and obsession.

The hypothesis behind this work is based on a clinical observation that a reasonable number of patients who use Captagone develop delusional jealousy more than patients using other substances do.

Patients and Methods

Study design:

A cross sectional questionnaire-based study.

Study subjects:

  • – Patients were recruited from patients admitted to Erada complex for mental health and addiction, Jeddah, Saudi Arabia during the period from September 2021 to March 2022.

Inclusion criteria:

  • – Patients admitted with the diagnosis of amphetamine (Captagon) induced psychosis.

  • – No history of primary psychiatric illness such as bipolar affective disorder (BAD), delusional disorders, or schizophrenia.

  • – Patients were using only Captagon at least during the last 12 months.

  • – Patients ages ranged between 18 and 60 years old.

  • – All patients were males.

  • – Consent to participate in the study.

Exclusion criteria:

  • – Patients who had a history of primary psychiatric illness, such as BAD, delusional disorders, or schizophrenia.

  • – Patients who used other substances such as cannabis or alcohol at least during the last 12 months.

  • – Patients refusing to consent to participate in the study.

Patients were subject to the following:

  • – All patients underwent an extensive psychiatric interview including interview with patients’ families.

  • – A demographic sheet.

  • – A drug use questionnaire.

  • – The structured clinical interview for DSM-IV (SCID 1).

  • – A routine medical investigation (e.g., renal function tests, liver function tests, CBC).

  • – Urine screening for drugs.

Ethics

The Committee for Research Ethics at Jeddah research and Studies Department, Jeddah Health Affairs, Saudi Arabia, has approved this study.

Statistics

Data were analyzed using SPSS 20.6 The Fischer exact test was used to test whether or not two categorical variables were associated with each other. Mann-Whitney U test was used to compare between two independent nonparametric variables. A p-value of less than 0.05 was considered significant.

Results

Patients’ ages ranged from 19 to 46 years old (Mean ± SD = 30.87 ± 6.58. 57). Fifty-eight patients (57.4%) were single, 77.2% have finished their high school, and 22.8% had no work. (Table 1)

Table 1. Patients’ Demographics.

Variable Frequency Percentage %
Age Mean ± SD 30.87 ± 6.58
Marital status
Single 58 57.4
Married 23 22.8
Divorced 19 18.8
Widow 1 1
Education
Primary 7 6.9
High 78 77.2
College 16 15.8
Occupation
Doesn’t work 23 22.8
Employee 71 70.3
Freelancer 2 2
Retired 5 5

Captagon using age ranged from 14 to 40 years old (Mean ± SD = 20.4 ± 5.45), and regular daily dose ranged from 1–15 tablet (Mean ± SD = 3.7 ± 2.2), while maximum daily dose ranged from 2–25 tablets (Mean ± SD = 7.2 ± 4.8). Sixty-eight patients (67.3%) have tried to stop using Captagon at least once.

Table 2 showed the prevalence of both delusions and hallucinations among the study group. Fifty-four patients (53.5%) have developed more than one type of delusions. Twenty-four patients (25.7%) of the study group have developed infidelity delusions.

Table 2. Frequency of Psychotic Features Among Study Population.

Number of patients Percentage of total number of patients
Delusions
Delusion of persecution 79 78.2%
Delusion of reference 40 39.6%
Delusion of infidelity 26 25.7%
Delusion of grandiosity 4 4%
Others 3 3%
Hallucinations
Auditory hallucination 58 57.4%
Visual hallucination 29 28.7%
Somatic hallucination 9 8.9%
Olfactory hallucination 1 1%

A higher divorce rate was present among patients who developed infidelity delusions (30.4%) in comparison to patients who developed other types of delusions (9.1%). (Table 3)

Table 3. Relationship Between Infidelity Delusions and Divorce.

Presence of infidelity delusions Absence of infidelity delusion Fischer exact test Sig.
Divorced 14 (53.8%) 5 (6.7%) 25.035 0.0001
Not divorced 12 (46.2%) 70 (93.3%)
Count 26 (100%) 75 (100%)

No differences were found between patients who developed infidelity delusions and those who did not regarding education, work, Captagone using age, daily Captagone dose, maximum Captagon dose, or trials to stop Captagone. Ages of patients with infidelity delusions were greater than those of patients with other types of delusions. (Table 4)

Table 4. Comparison Between Patients with Infidelity Delusions and Patients Without Regarding some Demographics.

Presence of infidelity delusions Absence of infidelity delusion Mann-Whitney U test Sig.
Age 34.52 ± 4.75 29.68 ± 6.72 –3.372 0.001
Daily Captagone dose 3.45 ± 1.88 3.77 ± 2.26 –0.267 0.79
Maximum Captagone dose 6.38 ± 3.81 7.47 ± 5.17 –0.595 0.552
Captagone using age 21.81 ± 6.69 19.91 ± 4.89 –1.354 0.176

Discussion

Delusional jealousy is the psychotic variant of morbid jealousy. Its prevalence was estimated among psychiatric inpatients to be 1.1% by Soyka et al.7 Delusional jealousy could be a presentation of organic disorders, personality disorder, substance use disorder, schizophrenia, or affective disorder.8 Women suffering from delusional jealousy commonly have the diagnosis of schizophrenia while alcohol-related psychosis is the common diagnosis among men.4

In their study, Singh, Bhandari, and Singh5 revealed that 20% of the patients presented with morbid jealousy; whether delusional or not; reported substance abuse like alcohol, cannabis, nicotine etc. either currently or in the past. They found also that delusional jealousy was commonly associated with substance use disorders.

Alcoholism was particularly linked in the literature with the occurrence of morbid jealousy. Michael et al,9 assessed morbid jealousy in 207 male patients with the diagnosis of alcohol dependence and they found that 34% suffered from morbid jealousy which had different manifestations including delusional disorder.

In their systematic review on antipsychotics for amphetamine psychosis, Fluyau, Mitra, and Lorthe,3 found that amphetamine users experienced different psychotic manifestations with high frequency of persecutory delusions, delusions of reference, and both auditory and visual hallucinations. Delusions of jealousy were not as common as delusions of persecutions or reference. This is in partial agreement with the results of this study as delusion of persecution were the most common type of delusions followed by delusion of reference. Also, auditory hallucination was the most common type of hallucinations followed by visual hallucination. The frequency of both delusions of reference and visual hallucinations were not so high as in Fluyau, Mitra, and Lorthe3 study. Also, delusions of jealousy were not uncommon as found in their study affecting about one fourth of our study population.

In their study which addressed amphetamine Versus Non-Amphetamine-Related First Episode Psychosis in Saudi Arabian Patients, El-dosoky et al,10 revealed a similar pattern of psychotic manifestations in patients diagnosed with amphetamine induced psychosis. Auditory and visual hallucinations, and delusions of reference and persecutions were the common psychotic manifestations in these patients. However delusional jealousy was not addressed in their study.

According to Batinic, Duisin & Barisic,8 morbid jealousy may be a presentation of substance use disorder such as cocaine or amphetamine. In an interesting case report, a man with a history of treatment for ADHD with dexamphetamine has developed infidelity delusions against his wife.11

In the present study no differences were found between patients who developed infidelity delusions and those who did not regarding patients’ demographics or demographics of Captagon use except for age variable. In Singh, Bhandari, and Singh5 study, morbid jealousy was more common in educated participants who attended intermediate level or university.

In the present study patients who developed delusional jealousy showed a higher divorce rate than patients with other types of delusions. Divorce may be a major social consequences of developing infidelity delusions but is not the most serious one. It is not uncommon for patients diagnosed with infidelity delusions to show both verbal and physical aggression toward their wives to a degree that endanger their lives. According to Singh, Bhandari, and Singh,5 delusional jealousy could give rise to fatal violence against the partner which may be followed by suicide.

This is an initial investigation of the association between using Captagon and the development of infidelity delusions. There is a need to replicate this study on a wider scale and to avoid limitations which included the non-randomized nature of the study, and lack of specific scale for morbid jealousy.

Conclusion

Infidelity delusions are common among patients diagnosed with Captagon induce psychosis, and they harmfully influence their social lives.

Footnotes

Conflict of Interests

There are no conflicts of interests.

Acknowledgments

Not applicable.

Funding

Nil.

Contributor Information

Amr Said Shalaby, Shalaby, MD, Eradah Complex for Mental Health and addiction, Eradah services, Jeddah, Saudi Arabia; Department of neuropsychiatry, Menoufia University, Egypt..

Osama Mohamed Badr Nassar, Nassar, MSc, Eradah Complex for Mental Health and addiction, Eradah services, Al-Taif, Saudi Arabia..

Abdullah Osama Bahanan, Bahanan, MBBCH, Eradah Complex for Mental Health and addiction, Eradah services, Jeddah, Saudi Arabia..

Mishal Hasan Alshehri, Alshehri, MBBCH, Eradah Complex for Mental Health and addiction, Eradah services, Jeddah, Saudi Arabia..

Nasr Farid Nasr Abou Elzahab, Elzahab, Eradah Complex for Mental Health and addiction, Eradah services, Jeddah, Saudi Arabia..

References

  • 1.Dabbagha R, Rawson R. Captagon Use in Saudi Arabia: What Do we Know. International Addiction Review . 2019;2(2):22–30. [Google Scholar]
  • 2.Katselou M, Papoutsis I, Nikolaou P, Qammaz S, Spiliopoulou C, Athanaselis S. Fenethylline (Captagon) Abuse-Local Problems from an Old Drug Become Universal. Basic Clin Pharmacol Toxicol . 2016;119(2):133–140. doi: 10.1111/bcpt.12584. doi: Epub 2016 Apr 8. PMID: 27004621. [DOI] [PubMed] [Google Scholar]
  • 3.Fluyau D, Mitra P, Lorthe K. Antipsychotics for Amphetamine Psychosis. A Systematic Review. Front. Psychiatry . 2019;10:740. doi: 10.3389/fpsyt.2019.00740. doi: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Kingham M, Gordon H. Aspects of Morbid Jealousy. Advances in Psychiatric Treatment . 2004;10(3):207–215. doi: 10.1192/apt.10.3.207. doi: [DOI] [Google Scholar]
  • 5.Singh SK, Bhandari SS, Singh PK. Phenomenology and Predisposing Factors of Morbid Jealousy in a Psychiatric Outdoor: A Cross-sectional, Descriptive Study. Open J Psychiatry Allied Sci . 2017;8(2):129–135. doi: 10.5958/2394-2061.2017.00008.8. doi: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. IBM Corp. Released 2020. IBM SPSS Statistics for Windows, Version 27.0. Armonk, NY: IBM Corp. [Google Scholar]
  • 7.Soyka M, Naber G, Völcker A. Prevalence of Delusional Jealousy in Different Psychiatric Disorders. An Analysis of 93 Cases. Br J Psychiatry . 1991;158:549–553. doi: 10.1192/bjp.158.4.549. doi: PMID: 2054570. [DOI] [PubMed] [Google Scholar]
  • 8.Batinic B, Duisin D, Barisic J. Obsessive versus Delusional Jealousy. Psychiatria Danubina . 2013;25(3):334–339. [PubMed] [Google Scholar]
  • 9.Michael A, Mirza S, Mirza KA, Babu VS, Vithayathil E. Morbid Jealousy in Alcoholism. Br J Psychiatry . 1995;167(5):668–672. doi: 10.1192/bjp.167.5.668. doi: PMID: 8564326. [DOI] [PubMed] [Google Scholar]
  • 10.EL Desoky E, El-Tantawy A, Raya Y, Al-Yahya A. Amphetamine Versus Non Amphetamine-Related First Episode Psychosis in Saudi Arabian Patients. Pharmacology & Pharmacy . 2011;2(3):101–108. doi: 10.4236/pp.2011.23013. doi: [DOI] [Google Scholar]
  • 11.Pillai K, Kraya N. Psychostimulants, Adult Attention Deficit Hyperactivity Disorder and Morbid Jealousy. Aust N Z J Psychiatry . 2000;34(1):160–163. doi: 10.1046/j.1440-1614.2000.00694.x. doi: PMID: 11185930. [DOI] [PubMed] [Google Scholar]

Articles from Psychopharmacology Bulletin are provided here courtesy of MedWorks Media Inc.

RESOURCES